In vitro and in vivo studies have reported the expression of YY1 has been associated with development of a malignant phenotype in some human cancers, tumor progression, metastasis formation, and correlating with poor prognosis and drug/immune resistance [8,9,10,11,12,13,14,15,16,17]. Here, YY1 is linked to cancer.